Biofrontera BFRI
NASDAQ BFRI
$0.80 +0.00 (+0.01%)
As of: Oct 22, 2026 · 3:37 PM EDT

Biofrontera (BFRI) Finished Goods (2024 - 2026)

Updated

Biofrontera (BFRI) recorded Finished Goods of $862,000 in Q2 2026.

Analysis

Biofrontera (BFRI) Finished Goods (2024 - 2026) Analysis & Trends

At the end of FY2025, Biofrontera reported Finished Goods of $1.43 million, down 78.5% from FY2024.

  • Across earlier years, Finished Goods came in at $6.65 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.46 Bn 1,139.04 Bn 19.71 Bn
2 Johnson & Johnson 648.38 Bn 568.24 Bn 17.30 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn
4 Merck 367.73 Bn 322.11 Bn 12.21 Bn
5 Novartis Ag 303.35 Bn 267.34 Bn 11.24 Bn
6 Astrazeneca 268.20 Bn 241.88 Bn 12.86 Bn
7 Amgen 242.55 Bn 197.95 Bn 7.24 Bn
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn
10 Biofrontera 10.34 Mn -11.45 Mn 9.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 862,000.00
Dec 31, 2025 1.43 Mn
Dec 31, 2024 6.65 Mn
API Access

Biofrontera Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=BFRI&period=max&api_key=YOUR_API_KEY